Pharmafile Logo
Pharmafocus logo
Advanced Search

Q1

Showing 15 posts of 37 posts found.

Merck KGaA’s sales climb but key drugs fall

May 19, 2015
Sales and Marketing Erbitux, Merck, Merck KGaA, Q1, Rebif

Merck KGaA encountered an uneven start to 2015, with robust sales in the first quarter offset by declines in key …

News
GSK image

Generics continue to erode GSK sales

May 6, 2015
Sales and Marketing GSK, HIV, Novartis, Q1, ViiV, Witty, hampton, respiratory

GlaxoSmithKline’s pharma sales continued to slide in the first quarter of 2015, but ViiV healthcare and the portfolios acquired from …

News
pfizer_building_side

Pfizer posts second consecutive quarterly income decline

April 29, 2015
Sales and Marketing 2015, Pfizer, Q1, first quarter

Pfizer made 4% less revenue in the first quarter of 2015 compared with the same period last year, the company’s …

News
Merck image

Merck sales fall in Q1 despite new product lifts

April 29, 2015
Sales and Marketing Merck, Q1, Remicade

Merck’s sales were down in the first quarter of 2015 thanks to its consumer care divestment and increasing competition for …

News
BMS image

BMS lifted by new products

April 28, 2015
Sales and Marketing BMS, NICE, Q1, eams, immuno-oncology and hepatitis C

New drugs have helped Bristol-Myers Squibb see a slight increase in sales for the first quarter of 2015. Total revenues …

News
Amgen image

Amgen files high earnings for Q1

April 22, 2015
Sales and Marketing AMG 334, Amgen, Corlanor, Kyprolis, Prolia, Q1, Xgeva, brodalumab, myeloma, osteoporosis

Amgen has boosted its first quarter profit by 51% due to surging drug sales and ongoing cuts that paved the …

News
Roche image

Roche buoyed by cancer drug sales

April 22, 2015
Sales and Marketing Actemra, Cancer, Esbriet, Esbriet., MabThera, Q1, Rituxan, RoActemra, Roche, Xolair, avastin, oncology

Pharma’s biggest cancer drugs maker Roche has reported strong sales growth on the back of its oncology portfolio for its …

News
J&J image

J&J strong pharma sales can’t offset Q1 losses

April 15, 2015
Sales and Marketing J&J, JJ, Q1, Waldenström's macroglobulinemia, Waldenström’s Macroglobulinemia, Zytiga, abiraterone acetate, financials, ibrutinib, imbruvica

Johnson & Johnson’s pharma division achieved worldwide sales of $7.7 billion in the first quarter of this year – but …

News
Ranbaxy image

Ranbaxy woes hit profits

May 13, 2014
Manufacturing and Production, Sales and Marketing Q1, Ranbaxy, Sun Pharma, manufacturing, recall

Indian generics maker Ranbaxy Laboratories has slipped up in the first quarter of the year, with profit sliding to 0.3 …

News
GSK image

GSK sees profit fall

May 1, 2014
Sales and Marketing Advair, China, GSK, Novartis, Q1, Seretide, Witty

GlaxoSmithKline has seen revenue and profit plummet in the first quarter of 2014. The UK-based company saw turnover fall 13% …

News
Merck image

Merck’s Q1 sales drop

April 30, 2014
Sales and Marketing AstraZeneca, Merck, Pfizer, Q1, merger, quarter, sales

Merck & Co has released a mixed set of results for the first quarter of 2014, with drug revenue falling …

News

Novartis reports healthy profit

April 25, 2014
Sales and Marketing Afinitor, Gleevec, Glivec, Novartis, Q1, lilly

Multiple sclerosis drug Gilenya and cancer treatment Afinitor were among the biggest sellers for Novartis, as the Swiss company’s net …

News
Astrazeneca image

Profits slump at AstraZeneca

April 24, 2014
Sales and Marketing AZD9291, AstraZeneca, BMS, Brilinta, Q1

AstraZeneca has continued its poor run of form, with operating profit in the first quarter of 2014 falling 40% on …

News
sovaldi iamge

Sovaldi performs for Gilead

April 24, 2014
Sales and Marketing Gilead, HCV, Q1, hepatitis C, sovaldi

Gilead Sciences’ once-daily, oral hepatitis C treatment Sovaldi has returned better than expected figures in the first quarter of the …

News
Sanofi image

Sanofi’s performance dives

May 3, 2013
Sales and Marketing Q1, Sanofi

Sanofi suffered a grim first three months of 2013, with sales dipping and profit plummeting as loss of exclusivity took …

News

Latest content

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024

FDA approves Roche’s HPV self-collection screening option

May 15, 2024

NHS accepts Pfizer’s tafamidis for ATTR-CM treatment

May 14, 2024